Crizotinib efficacy in ALK-positive advanced stage non-small cell lung cancer patients: a real-world experience from Turkey.
IASLC 19th World Conference On Lung Cancer, Canada, 23 - 26 September 2018, vol.13, pp.1020, (Full Text)
- Publication Type: Conference Paper / Full Text
- Volume: 13
- Doi Number: 10.1016/j.jtho.2018.08.1955
- Country: Canada
- Page Numbers: pp.1020
- Çukurova University Affiliated: Yes